OBJECTIVES:

• To assess ADRS by international parameters
• To Promote education, understanding, and clinical training in Pharmacovigilance, encourage the Public and health care professionals to report ADRs
• To establish the underlying reasons of ADRs such as hypersensitivity, idiosyncrasy overdosing, etc.
• Development of ADR ALERT CARD (YELLOW CARD SYSTEM) with the help Of physicians and Clinical Pharmacist and promoting its usage.

METHODS:

The suspected or identified adverse drug reactions were recorded in IPC- PvPI suspected adverse drug reactions form. After collecting the adverse drug reactions were analyzed for the causality with the help of Causality assessment scales such as Naranjo algorithm scale and WHO-UMC causality scale, preventability by Modified Shumock and Thorton’s preventability criteria, and severity by Modified Hartwig and Seigal severity scale, Using Rawling and Thompson scale the adverse drug reactions were classified to understand the type of reaction. An impact of educational interventions of adverse drug reactions Was assessed by using Pre-KAP and Post KAP survey questionnaires among nurse and interns.

RESULTS:

Prevalence of ADR’s was found to be 8.02% and male to female ratio was 0.81. ADR’s mostly occurred in the age group 41-50 (57.4%). Ski and gastrointestinal was found to be the most commonly affected organ system (24.29%) among which rashes and urticaria were the most common type of ADR’S reported, majority of the adverse drug reactions were due to Antimicrobials (22.42%).

CONCLUSIONS:

one should need to observe the patient prescription and compliance towards medications. so that we can minimize the adverse drug reactions. The study concludes that involving clinical pharmacist services in patients care can significantly helps to identify, the suggestions provided by the clinical pharmacist during the intervention were well accepted by the physician thus the collaborative approach of physician and clinical pharmacist can provide better patients centre care outcomes.